Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/20/2020 11/23/2020 11/24/2020 11/25/2020 11/27/2020 Date
80.45(c) 80.28(c) 80.14(c) 80.06(c) 79.86(c) Last
8 031 403 9 063 500 12 206 441 5 747 728 5 386 008 Volume
+0.07% -0.21% -0.17% -0.10% -0.25% Change
More quotes
Financials (USD)
Sales 2020 48 147 M - -
Net income 2020 11 964 M - -
Net Debt 2020 14 612 M - -
P/E ratio 2020 17,0x
Yield 2020 3,05%
Sales 2021 51 546 M - -
Net income 2021 14 733 M - -
Net Debt 2021 12 189 M - -
P/E ratio 2021 15,2x
Yield 2021 3,24%
Capitalization 202 B 202 B -
EV / Sales 2020 4,50x
EV / Sales 2021 4,16x
Nbr of Employees 71 000
Free-Float 70,7%
More Financials
Company
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or... 
Sector
Pharmaceuticals
Calendar
12/14Ex-dividend day for
More about the company
All news about MERCK & CO., INC.
11/27OF MOLECULES & MEDICINE : Dr Maurice Hilleman ("The Father Of Modern Vaccines")
AQ
11/24MERCK : Submits Applications for Licensure of V114, the Company's Investigationa..
AQ
11/24CORCEPT THERAPEUTICS INCORPORATED : Appoints Gillian M. Cannon, PhD, to Board of..
AQ
11/24MERCK : to Acquire OncoImmune
AQ
11/23GLOBAL MARKETS LIVE: Boeing’s 737 Max to resume flights in Europe, Merck’s la..
11/23MERCK : Correction to Merck to Buy OncoImmune Article
DJ
11/23Merck to Buy OncoImmune for $425 Million Amid Race for Covid-19 Treatments --..
DJ
11/23MERCK : Applies in U.S., Europe to License V114 Pneumococcal Conjugate Vaccine
DJ
11/23Merck to Buy OncoImmune Amid Covid-19 Vaccine Development
DJ
11/23MERCK : Submits Applications for Licensure of V114, the Company's Investigationa..
BU
11/23MERCK : to Acquire OncoImmune
BU
11/20EISAI : To present new investigational data on lenvima in thyroid cancer and ost..
AQ
11/19IMMUTEP : Announces Expansion of TACTI-002 Collaboration Trial
AQ
11/18MERCK : Announces First-Quarter 2021 Dividend
AQ
11/18MERCK : Unveils New Website for Global Study for Monitoring Antimicrobial Resist..
PU
More news
News in other languages on MERCK & CO., INC.
11/24Planète Bourse - La revue de presse du mardi 24 novembre 2020
11/23Les valeurs à suivre aujourd'hui à Wall Street Lundi 23 novembre 2020
11/23MERCK : rachète OncoImmune
11/23MERCK : dossiers déposés pour un vaccin antipneumococcique
11/23MERCK : accord pour l'acquisition d'OncoImmune
More news
Analyst Recommendations on MERCK & CO., INC.
More recommendations
Stock Trading Strategies
MERCK & CO., INC - 03/26
Good timing to go long again
BUY
More Stock Trading Analysis
Chart MERCK & CO., INC.
Duration : Period :
Merck & Co., Inc. Technical Analysis Chart | MRK | US58933Y1055 | MarketScreener
Technical analysis trends MERCK & CO., INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Average target price 96,05 $
Last Close Price 79,86 $
Spread / Highest target 34,0%
Spread / Average Target 20,3%
Spread / Lowest Target 6,44%
EPS Revisions
Managers
NameTitle
Kenneth C. Frazier Chairman, President & Chief Executive Officer
Robert M. Davis CFO & Executive Vice President-Global Services
Sandy Tremps Vice President-R&D IT CIO
Thomas Henry Glocer Independent Director
Leslie A. Brun Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MERCK & CO., INC.-12.19%202 049
DAIICHI SANKYO COMPANY, LIMITED56.60%72 682
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 850
YUNNAN BAIYAO GROUP CO.,LTD7.23%18 673
ORION OYJ-3.10%6 712
SWEDISH ORPHAN BIOVITRUM AB1.42%5 440